According to a report by Triton Market Research, the Asia-Pacific market for cellulite treatment is projected to grow at a CAGR of 9.83% from 2023 to 2030. The report evaluates the market across several countries in the region, which includes China, Japan, India, South Korea, Australia & New Zealand, ASEAN countries, and Rest of Asia-Pacific.
China hosts a considerable number of skilled plastic surgeons, and their presence is expected to play a key role in driving the studied market’s growth. The beauty and personal care product industry in China is one of the largest in the world. In this regard, the rise in demand for premium beauty products and services has further strengthened the industry’s growth. Therefore, the beauty sector’s expansion creates opportunities for the cellulite treatment market.
Japan stands out with the highest number of cosmetic procedures globally. The demand for anti-aging, brightening, and moisturizing products remains high in Japan, and as a result, the cosmetics and personal care industry has been expanding. Besides this, technological advancements and the rise in medical tourism have soared the demand for various cosmetic procedures, including cellulite reduction. This further accelerates the cellulite treatment market’s development.
Competitive Outlook
The notable companies in the cellulite treatment market consist of Bausch Health Companies Inc, Cutera Inc, Galderma SA, Endo International Plc, and Sientra Inc.